Skip to content
TECHNOLOGIES FOR VIRAL VECTORS & VACCINES

Overview Technologies

Bring your viral vectors or viral vaccines to the next level with our cutting-edge technologies. From unique vector strains and designer cell lines to advanced packaging and producer cell lines, we provide innovative solutions to ease your development and enhance your production processes. 

IN A NUTSHELL

Stellar Technologies for Viral Vectors and Vaccines

ProBioGen provides all components for successful viral vector and vaccine development, from vector design to expression systems, from process development to GMP manufacturing. We offer a smart molecular and cellular toolbox to create high-performance vectors.

Our expertise in process development and GMP manufacturing ensures customized production for the desired scale, from preclinical material to clinical batches. 

Technologies for Viral Vectors and Vaccines
WHAT WE OFFER

 

Explore Our Technologies

MVA Vector Platform

MVA Vector Platform MVA.CR19

DirectedLuck Transposase

 Transposase System DirectedLuck®

Lenti.RiGHT Production System

 Lentivirus Production System Lenti.RiGHT®

AGE1 Designer Cell Line

Designer Cell Line AGE1®

Elevate Your Candidate With The Right Technology 

Explore Related Services for Virals

End-to-end CDMO Services

End-to-End CDMO Services

Producer Cell Line Development

Producer Cell Line Development

Process Development


Process Development

GMP Manufacturing


GMP Manufacturing

Quality Analytics

 
Quality Analytics

AAV Production


AAV Production

Lentivirus Production


Lentivirus Production

Poxvirus Production


Poxviruses Production

+

Cell Lines Developed

<

Months from Gene to DP

~

GMP Batches/Year

Explore Related Content

Rethinking LVV Manufacturing for Scalable Success
Beyond the Bottleneck – Rethinking LVV Manufacturing for Scalable Success

Blog Post

Read More
ProBioGen_und das Berlin Institute of Health in der Charité (BIH) kooperieren im Berlin Center for Gene und Cell Therapies (BC GCT)-3
ProBioGen to Lead GMP Manufacturing Operations at Berlin Center for Gene and Cell Therapies (BC GCT)

Press Release

Read More
Transient_Transfection_Blog_Small-1
Transient Transfection for Lentiviral Vector Production Has Taken Us Far—But Can It Take Us Further?

Blog Post

Read More
Blog Header template-2
ProBioGen Enters Agreement with Polpharma Biologics to Provide High-Performance Cell Line Development Services

Press Release

Read More
Newsletter
Join for ProBioGen News - make sure to be always up-to-date and fully informed with our latest company announcements.